![Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-018-0529-2/MediaObjects/13052_2018_529_Fig1_HTML.png)
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
![Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2FBF03262128/MediaObjects/40267_2012_2128_FigU1.jpg)
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
![Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram](https://www.researchgate.net/publication/258102812/figure/fig1/AS:202846071988228@1425373680509/Recommended-clinical-guideline-for-the-management-of-Kawasaki-disease-in-the-UK-Since.png)
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
![Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S147148922030059X-gr1.jpg)
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect
![Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a](https://www.thelancet.com/cms/attachment/5d113c51-9037-44ef-bf21-ef221a51cd49/gr1.gif)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
![Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health](https://www.thelancet.com/cms/asset/4dd43524-dcf7-466a-a39e-5413f3d8ea78/gr1.gif)
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
![Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-00962-4/MediaObjects/13052_2021_962_Fig1_HTML.png)